WHO Expert Committee on Biological Standardization
- PMID: 15497598
WHO Expert Committee on Biological Standardization
Abstract
This report presents the recommendations of a WHO Expert Committee commissioned to coordinate activities leading to the adoption of international recommendations for the production and quality control of vaccines and other biologicals and the establishment of international biological reference materials. The report starts with a discussion of general issues brought to the attention of the Committee and provides information on issues relevant to international guidelines, recommendations and other matters related to the manufacture and quality control of biologicals. This is followed by information on the status and development of reference materials for bovine spongiform encephalopathy, various antigens, blood products, cytokines, growth factors and endocrinological substances. The second part of the report, of particular interest to manufacturers and national control authorities, contains sets of recommendations for the production and control of poliomyelitis vaccine (oral) and poliomyelitis vaccine (inactivated) and guidelines for the production and control of live attenuated Japanese encephalitis vaccine. Also included are lists of recommendations and guidelines for biological substances used in medicine, and other relevant documents.
Similar articles
-
WHO Expert Committee on Biological Standardization.World Health Organ Tech Rep Ser. 2006;932:v-vi, 1-137. World Health Organ Tech Rep Ser. 2006. PMID: 17274191
-
Who Expert Committee on Biological Standardization.World Health Organ Tech Rep Ser. 2004;926:1-109. World Health Organ Tech Rep Ser. 2004. PMID: 15918537
-
WHO Expert Committee on Biological Standardization.World Health Organ Tech Rep Ser. 2002;904:i-vi, 1-107. World Health Organ Tech Rep Ser. 2002. PMID: 11980231
-
Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.Biologicals. 2010 Jan;38(1):162-9. doi: 10.1016/j.biologicals.2009.08.019. Epub 2009 Oct 8. Biologicals. 2010. PMID: 19818645 Review.
-
WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1-2 June 2006.Vaccine. 2007 Jul 20;25(29):5233-43. doi: 10.1016/j.vaccine.2007.05.034. Epub 2007 Jun 8. Vaccine. 2007. PMID: 17590244
Cited by
-
Inclusivity and diversity: Integrating international perspectives on stem cell challenges and potential.Stem Cell Reports. 2021 Aug 10;16(8):1847-1852. doi: 10.1016/j.stemcr.2021.07.003. Epub 2021 Jul 29. Stem Cell Reports. 2021. PMID: 34329597 Free PMC article.
-
Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India.BMC Infect Dis. 2014 Mar 21;14:156. doi: 10.1186/1471-2334-14-156. BMC Infect Dis. 2014. PMID: 24656175 Free PMC article. Clinical Trial.
-
Non-animal replacement methods for human vaccine potency testing: state of the science and future directions.Procedia Vaccinol. 2011;5:16-32. doi: 10.1016/j.provac.2011.10.002. Epub 2011 Dec 23. Procedia Vaccinol. 2011. PMID: 32288913 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical